1Wang Y, Moore JK, Ng TC, et al. Diffetentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1HMRS[J]. Mag Reso Med, 1998,39:28-33.
2Christiansen P, Toff P, Larsson, et al. The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium[J]. Mag Reso Imag, 1993,11:799-806.
3Tate AR, Griffiths JR, Martinez-Perez I, et al. Towards a method for automated classification of 1HMRS spectra from brain tumours[J ]. NMRBiomed, 1998,11(4-5): 177-191.
4Poptani H, Kaartinen J, Gupta RK, et al. Diagnostic assessment of brain tumours and non-neoplastic brain disorders in vivo using proton nuclear magnetic resonance spectroscopy and artificial neural networks [ J ]. J Cancer Res Clin Oncol, 1999, 125(6):343-349.
5Kinoshita Y, Kajiwara H, Yokota A, et al. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study [ J ]. Neurosurgery,1994,35(4):606-614.
6Gill SS,Grin W,Nakhla B,et al. Proton MR spectroscopy of intracranial tumors: In vivo and in vitro studies[J]. J Comput Assist Tomogr,1990, 14:497-504.
7Norfray JF, Darling C, Byrd S, et al. Short TE proton MRS and neurofibromatosis type 1 intracranial lesions [J ]. J Comput Assist Tomogr,1999,23(6):994-1003.
8Arle JE, Morriss C, Wang ZJ, et al. Prediction of posterior fossa tumor type in children by means of magnetic resonance image properties, spectroscopy, and neural networks[J ]. J Neurosurg, 1997,86:755-561.
9Lin A,Bluml S, Mamelak AN,ct al. Efficacy of proton magnetic resonance spectroscopy in clinical decison making for patients with suspect ed malignanl brain tumors [J]..J Neurooneol, 1999,45(1):69-81.
